Abstract Purpose of Review Idiopathic pulmonary fibrosis (IPF) is the most common form of
interstitial lung disease of unknown etiopathogenesis with mean survival of 3–5 years and …

Idiopathic pulmonary fibrosis (IPF), a chronic progressive interstitial pneumonia, is
characterized by excessive fibroproliferation. Key effector cells in IPF are myofibroblasts that …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, incurable lung disease of
unknown etiology with only limited treatment options. Current paradigms of disease …

Idiopathic pulmonary fibrosis (IPF) is a form of progressive interstitial lung disease with
unknown etiology. Due to a lack of effective treatment, IPF is associated with a high mortality …

Idiopathic pulmonary fibrosis (IPF), a progressive and relentless lung scarring of unknown
etiology, has been recognized as the most lethal interstitial lung disease. Despite the …

An understanding of the mechanisms underlying pulmonary fibrosis remains elusive. Once
believed to result primarily from chronic inflammation, it is now clear that inflammation and …

Idiopathic pulmonary fibrosis (IPF) is one of a group of interstitial lung diseases that are
characterized by excessive matrix deposition and destruction of the normal lung …

Idiopathic pulmonary fibrosis (IPF) is a progressive disease of the middle aged and elderly
with a prevalence of one million persons worldwide. The fibrosis spreads from affected …

Idiopathic pulmonary fibrosis (IPF) is the most common form of interstitial lung disease
characterized by the persistence of activated myofibroblasts resulting in excessive …

Idiopathic pulmonary fibrosis (IPF) is a progressive, irreversible, and rapidly fatal interstitial
lung disease marked by the replacement of lung alveoli with dense fibrotic matrices …